Artificial Life, Inc.
ALIF · OTC
12/31/2010 | 12/31/2009 | 12/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.28 | -0.18 | 0.01 | -0.54 |
| FCF Yield | -9.77% | -15.07% | -23.08% | -7.48% |
| EV / EBITDA | 4.57 | 3.79 | 3.32 | 166.62 |
| Quality | ||||
| ROIC | 10.07% | 14.60% | 36.32% | 0.52% |
| Gross Margin | 70.90% | 80.66% | 72.85% | 63.57% |
| Cash Conversion Ratio | 1.03 | -0.29 | 0.31 | -3.36 |
| Growth | ||||
| Revenue 3-Year CAGR | 16.50% | 67.89% | 197.09% | 179.13% |
| Free Cash Flow Growth | 16.44% | 26.16% | -82.00% | -103.20% |
| Safety | ||||
| Net Debt / EBITDA | -0.01 | -0.01 | 0.02 | -11.27 |
| Interest Coverage | 90.27 | 44.25 | 46.44 | 0.29 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 125.10 | 80.96 | 185.19 | 204.86 |